We have approved
the information collection activities in the Women's Health
Initiative for the maximum period permitted under the PRA. To
maximize the practical utility of this study, NIH and its collabora
rs should make special efforts to enroll disadvantaged and
hard-to-rea women into the cohort.
Inventory as of this Action
Requested
Previously Approved
06/30/1997
06/30/1997
84,315
0
0
94,433
0
0
0
0
0
S HEALTH, MENOPAUSE, CANCER,
CARDIOVASCULAR DISEASE, OSTEPOROSI THE OBSERVATIONAL STUDY WILL
PROVIDE NEEDED INFORMATION ON HEALTH AND DISEASE RISKS FOR WOMEN.
THIS STUDY WILL COLLECT DATA FROM 100,000 POSTMENOPAUSAL WOMEN ON
BIOMARKERS AND RISK FACTORS FOR DISEASE, AND T WOMEN WILL BE
FOLLOWED FOR AVERAGE OF YEARS TO DETERMINE ASSOCIATIONS THESE
MEASUREMENTS WITH DISEASE. THE AGGREGATE INFORMATION WILL BE
ANALYZED AND REPORTED IN APPROPRIATE JOURNALS.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.